Header Ads

Among the vaccine skeptics: a new podcast

Here's the latest news from the global pandemic.

Among the vaccine skeptics: a new podcast

Initially, Jonathan Damato didn't just plan to get vaccinated — he was actually excited about it.

Damato, a 41-year-old New York City paramedic, spent the past year on the frontlines of the coronavirus pandemic. Going to work each day meant not only exposing himself to Covid-19, but also his wife and five children. While he wanted to keep his family safe, he also wanted to help end a pandemic that kept his children home from school and much of the world in a virtual shutdown. 

Then one day Damato received a text from his aunt. She sent him a link to a YouTube video that was basically a greatest-hits compilation of Covid vaccine misinformation. After watching it and then doing a little more research on his own, Damato was no longer so sure about getting a shot.

"There are too many questions that I have," he says in "Doubt," a new podcast from Bloomberg Prognosis that makes its debut Tuesday. He now worries about the risk of potential side effects that could leave him unable to provide for his family, or worse.

"I'm torn between both, you know, I really am," Damato says. "I'm torn between both."

Damato's story is the subject of the first episode of "Doubt," a series that delves deep into the complex and myriad forces that have led so many people like him to question vaccines over the past year.

Concerns about vaccines aren't new, of course. They've existed for as long as vaccines have. But the modern wave of skepticism can be traced to the 1980s and '90s, when parents had misguided fears about mercury in vaccine solutions, and British physician Andrew Wakefield published a now-debunked paper that falsely linked the MMR vaccine to autism.

Vaccines are a technology. And for that technology to work, it requires trust in public institutions, says Heidi Larson, the founder of the Vaccine Confidence Project at the London School of Hygiene & Tropical Medicine.

Unfortunately, in an era of political polarization where even a recommendation to wear a mask can be seen as an affront to personal freedom, that trust has eroded.

"Sometimes the rumor is not really about the rumor. It's about a lot of distrust," she says. "If people trust the system, they're not out there looking for rumors. If you don't trust the system, you're much more gullible to conspiracies than others."— Kristen V . Brown

The next-generation vaccines

The New Vaccines Will Be Easier and Better

The next generation includes shots built from the coronavirus genetic material and nasal sprays that defend without using a needle at all. They are stealthy, faster to make and easier to ship, offering workarounds for hurdles that limit the impact of the first inoculations. Learn about them here.

A Covid-19 vaccination center in Rome.

Photographer: Alessia Pierdomenico/Bloomberg

Join Us Today | Bloomberg New Economy Conversations with Andrew Browne: Big Pharma joined with governments to deliver vaccines in record time. The successful moonshot could spur future research into other affordable drugs. Join us today, March 23, at 10 a.m. EDT when Katalin Karikó, senior vice president of vaccine pioneer BioNTech, and others discuss Vaccine Miracles and the New Promise of Science. Register here.

What you should read

Variants Rise in Some States, Adding Urgency
U.S. officials are again raising alarms about the resurgence of cases.
Singapore Is Planning for Post-Covid Office Life
Less-crowded trading floors and split work areas could all become routine.
China Reliance Hurts Hong Kong Vaccine Rollout
Confidence in Sinovac and the government's vaccine drive has plummeted.
Merkel Imposes Radical Easter Lockdown 
Germany tries to defuse a "third wave." 
Kremlin Touts Putin Shot; No Cameras Allowed
The President "is no fan" of getting his shot on camera.

Know someone else who would like this newsletter? Have them sign up here.

Have any questions, concerns, or news tips on Covid-19 news? Get in touch or help us cover the story.

Like this newsletter? Subscribe for unlimited access to trusted, data-based journalism in 120 countries around the world and gain expert analysis from exclusive daily newsletters, The Bloomberg Open and The Bloomberg Close.

No comments